To Evaluate the Treatment Effect of an Anti-Infective Agent for Different Kinds of Infections (0826-052)
PHASE3CompletedINTERVENTIONAL
Enrollment
30
Participants
Timeline
Start Date
July 31, 2005
Primary Completion Date
January 31, 2006
Study Completion Date
January 31, 2006
Conditions
InfectionPneumoniaUrinary Tract Infection
Interventions
DRUG
MK0826, ertapenem sodium / Duration of Treatment: 14 Days
All Listed Sponsors
lead
Merck Sharp & Dohme LLC
INDUSTRY
NCT00398099 - To Evaluate the Treatment Effect of an Anti-Infective Agent for Different Kinds of Infections (0826-052) | Biotech Hunter | Biotech Hunter